不分化割抗性前列腺癌成功用卡博普拉丁和帕克利塔克塞尔治疗
Masayuki Sano1, Masaki Shimbo1, Shin Ohgita2
1Department of Urology, St. Luke's International University, Tokyo, Japan.
Case reports in urology
|March 2, 2026
概括
这项案例研究表明,碳白和帕克利塔塞尔化学疗法可以有效地治疗在没有雄激素受体表达的患者中具有攻击性,差异化抵抗性前列腺癌 (CRPC) 的患者. 对高级前列腺癌基于的治疗方法进行进一步的研究是有必要的.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 医学案例报告 病例报告
背景情况:
- 抗化前列腺癌 (CRPC) 是一种具有有限治疗策略的侵袭性恶性瘤,特别是在缺乏雄激素受体表达的差异化亚型中.
- 在这些晚期病例中,常规疗法往往被证明是无效的,需要探索替代治疗方式.
研究的目的:
- 报告一种罕见的差异化CRPC病例,该病例对特定的化疗疗法有显著的反应.
- 突出卡博普拉丁和帕克利塔克塞尔在治疗侵袭性前列腺癌变体方面的潜力.
主要方法:
- 一名53岁的男性患者患有转移性割敏感前列腺癌,尽管接受了抗雄激素剥夺治疗,但进展到CRPC.
- 免疫组织化学证实差差分化的癌症,不包括神经内分泌分化.
- 系统化疗使用卡博普拉丁 (曲线下面的面积为5) 和帕克利塔塞尔 (200 mg/m2) 进行.
主要成果:
- 患者在治疗2个月内实现了部分缓解.
- 在18个月后,完全缓解得到证实,在73个化疗周期后持续缓解.
- 在随访期间,患者仍然处于缓解状态.
结论:
- 卡博普拉丁和帕克利塔克塞尔在治疗差异化不良的CRPC方面表现出显著的疗效.
- 这一案例表明,以为基础的化疗方案可能是攻击性前列腺癌亚型的可行选择.
- 建议进行进一步的临床研究,以评估高级和差异化前列腺癌的基疗法.
相关概念视频
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K


